Cornelia Haag und Urovant Sciences - Info zur Person

(1 - 18 von 19

)

Urovant Sciences Announces U.S. FDA Approval of ...Sumitomo Pharma America

www.us.sumitomo-pharma.com

... Cornelia Haag-Molkenteller, M.D., Ph.D., chief medical officer of Urovant Sciences. “By successfully treating clinical symptoms, GEMTESA may allow patients ...

Urovant Sciences Initiates Patient Enrollment in Phase AP Newsapnews.com › ...

apnews.com

· ... of our New Drug Application with the FDA for Vibegron in OAB,” said Cornelia Haag-Molkenteller, Chief Medical Officer of Urovant Sciences.

Cornelia Haag, Chief Medical Officer, Urovant Sciences

www.topionetworks.com

Curated profile of Cornelia Haag, Chief Medical Officer, Urovant Sciences including career history, news and intelligence, portfolio companies and investments.

Urovant Sciences Announces Topline Data from Business Wirewww.businesswire.com › news › home

www.businesswire.com

· ... investigators and their site staff who participated,” said Cornelia Haag- Molkenteller, M.D., Ph.D., chief medical officer of Urovant Sciences.

Dr Cornelia Haag - Molkenteller Urovant SciencesInternational Continence Society

www.ics.org

Dr Cornelia Haag - Molkenteller Urovant Sciences. Profile; Committees; Faculty; Disclosures. View ICS Member Details. Cornelia Haag - Molkenteller.

Cornelia Haag-Molkenteller active positionsMarketScreener

www.marketscreener.com

Cornelia Haag-Molkenteller is Chief Medical Officer of Urovant Sciences, Inc. and Chief Medical Officer & Executive Vice President at Urovant Sciences Ltd.

Cornelia Haag-Molkenteller - Biography

www.marketscreener.com

Currently, Cornelia Haag-Molkenteller holds the position of Chief Medical Officer & Executive Vice President at Urovant Sciences Ltd. and Chief Medical Officer...

Pharmacokinetics and Safety of Vibegron 75Â€mg ...John Wiley

accp1.onlinelibrary.wiley.com

von J King · · Zitiert von: 2 — This study was funded by Urovant Sciences. Conflicts of Interest. Jennifer King and Cornelia Haag-Molkenteller were employ- ees of Urovant Sciences at the time ...

Science is an Art for Urovant CMO Cornelia Haag ...BioSpace

www.biospace.com

— For Cornelia Haag-Molkenteller, M.D., Ph.D., CMO at Urovant Sciences, that means modern art and music – in particular, opera. Haag-Molkenteller ...

Cornelia Haag's Post - Urovant Scienceslinkedin.com

www.linkedin.com

Cornelia Haag's Post. View profile for Cornelia Haag · Cornelia Haag. Consultant. 2y. Report this post; Close menu. Urovant Sciences. View ...

Cornelia Haag-Molkenteller - Biographie - Zone Boursewww.zonebourse.com › barons-bourse › biograp...

www.zonebourse.com

Presently, Cornelia Haag-Molkenteller is Chief Medical Officer of Urovant Sciences Ltd. and Chief Medical Officer of Urovant Sciences, Inc. In the past she ...

Urovant Sciences Announces Topline Data from Phase Sumitovantwww.sumitovant.com › ...

www.sumitovant.com

... thank the patients, investigators and their site staff who participated,” said Cornelia Haag-Molkenteller, M.D., Ph.D., chief medical officer of Urovant Sciences.

Urovant Sciences Announces U.S. FDA Acceptance of ...Sumitomo Pharma America

www.sumitovant.com

Cornelia Haag-Molkenteller, Chief Medical Officer of Urovant Sciences. “The symptoms of overactive bladder affect over 30 million people in the United ...

Women-Leader-Magazine-Oct21 ArchivesInsights Care

insightscare.com

Cornelia Haag-Molkenteller of Urovant Sciences Inc. Dr. Cornelia Haag-Molkenteller: Letting Innovation Lead the Way · Natalie Bartlett | Chief of Staff ...

Urovant Strengthens Management Team and Establishes its U.S....

www.biospace.com

Urovant Sciences has been busy the past few weeks. In March the company initiated a Phase III trial for an overactive bladder treatment, strengthened its...

UROVANT SCIENCES LTD (UROV) Q Earnings Call Transcript | The...

www.fool.com

UROV earnings call for the period ending June 30,

Urovant Sciences Initiates Patient Enrollment in Phase 2a Study of...

www.nasdaq.com

IRVINE, Calif.& BASEL, Switzerland---- Urovant Sciences, announced today that the first patient has been enrolled in a Phase 2 a study evaluating the efficacy...

Urovant Sciences vibegron fails Phase 2a IBS trial | BioTuesdaysbiotuesdays.com ›

biotuesdays.com

· In a statement, Cornelia Haag-Molkenteller, M.D., Ph.D., Urovant's chief medical officer, said, “We look forward to advancing our Phase

Alle Infos zum Namen "Cornelia Haag"

Verwandte Suchanfragen zu Cornelia Haag

Jennifer King
Johannes Haag
Cornelia Burk

Günter Haag
Sabrina Haag
Cornelia Kästel

Murat Fidanverdi
Guenter Döll

Person "Haag" (15)
Vorname "Cornelia" (25578)
Name "Haag" (2438)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Cornelia Haag und Urovant Sciences Person-Info